• Partnering for CNS disorders

• Taking a journey through gene therapy

• How to prepare for a pharmaceutical deal

• Immuno-oncology: no stopping the checkpoint inhibitors

• Realising the market potential of antibody–drug conjugates

• Pharma deals put women's health on the therapeutic map

• The commercial landscape for infectious disease vaccines

• Pharma dealmaking: uncovering strategic trends

• Medtech dealmaking and financing trends

• A year in diagnostic deals

• Mapping collaborations in the microbiome field

• Cancer vaccine development reignited by neoantigens

• Dermatology market on brink of growth spurt